Application Protocol for OASIS® Wound Matrix
|
These recommendations are designed to serve only as a general guideline, and are not intended to supersede institutional protocols or professional clinical judgment concerning patient care. |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||
|
What to Expect: Caramelization
Note:
STERI-STRIP is a registered trademark of 3M. |
||||||||||||||||||||||||
OASIS is a registered trademark of Cook Biotech, Inc. Healthpoint is a registered trademark of Healthpoint, Ltd.
© 2011 Healthpoint Biotherapeutics. All rights reserved.
The information on this site is intended for customers, patients, and healthcare professionals in the United States only. All information, including the Prescribing Information forOASIS® Wound Matrix and OASIS® Ultra, abides by the laws, regulatory requirements, and medical practices for the United States only and may not be appropriate for use outside of the United States.
For help with reimbursement questions, please call our national hotline at 1-877-805-5055 between 9AM - 7PM EST Monday through Friday.
© 2011 Healthpoint Biotherapeutics. All rights reserved.
The information on this site is intended for customers, patients, and healthcare professionals in the United States only. All information, including the Prescribing Information for
For help with reimbursement questions, please call our national hotline at 1-877-805-5055 between 9AM - 7PM EST Monday through Friday.









